医学
重症肌无力
2019年冠状病毒病(COVID-19)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
梅德林
重症监护医学
疾病
神经肌肉疾病
冠状病毒
免疫学
内科学
病毒学
传染病(医学专业)
爆发
政治学
法学
作者
Syed Muhammad Ismail Shah,Farah Yasmin,Roha Saeed Memon,Nadia Nazir Jatoi,Ilma Saleh Savul,Sana Kazmi,Syed Abdullah Monawwer,Muhammad Daim Bin Zafar,Muhammad Sohaib Asghar,Muhammad Junaid Tahir,Ka Yiu Lee
摘要
This review highlights the potential mechanisms of neuromuscular manifestation of COVID-19, especially myasthenia gravis (MG).An extensive literature search was conducted by two independent investigators using PubMed/MEDLINE and Google Scholar from its inception to December 2020.Exacerbations of clinical symptoms in patients of MG who were treated with some commonly used COVID-19 drugs has been reported, with updated recommendations of management of symptoms of neuromuscular disorders. Severe acute respiratory syndrome coronavirus 2 can induce the immune response to trigger autoimmune neurological disorders.Further clinical studies are warranted to indicate and rather confirm if MG in the setting of COVID-19 can pre-existent subclinically or develop as a new-onset disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI